Brookfield Asset Management Inc. Aurinia Pharmaceuticals Inc. Transaction History

Brookfield Asset Management Inc.

  • $14 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$8.96 - $11.69 $1.35 Million - $1.76 Million
150,633 New
150,633 $1.46 Million
Q4 2021

Feb 14, 2022
BUY
$17.78 - $33.08 $3.4 Million - $6.33 Million
191,482 Added 394.66%
240,000 $5.49 Million
Q3 2021

Nov 16, 2021
BUY
$10.93 - $23.55 $13,236 - $28,519
1,211 Added 2.56%
48,518 $1.07 Million
Q2 2021

Aug 17, 2021
BUY
$10.0 - $14.52 $473,070 - $686,897
47,307 New
47,307 $613,000

Others Institutions Holding AUPH

# of Institutions
214
Shares Held
58.3M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.13B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Brookfield Asset Management Inc. Portfolio

Follow Brookfield Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brookfield Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email